Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (261-270 of 436) with videos related to

Pageof 44
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Haematology and Blood Transfusion|January 1, 1979
Treatment of adult acute myeloblastic leukemiaK B McCredie, M J Keating, K A Dicke, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsV Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Leukemia & Lymphoma|July 27, 2016
Long-Term Results of CAP Therapy in Chronic Lymphocytic LeukemiaM J Keating, J P Hester, K B McCredie, et al.
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
International Journal of Oncology|February 17, 2000
Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic miceM A Haidar, T Manshouri, M J Keating, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 44

Showing results (261-270 of 436) with videos related to

Sort By:
Pageof 44
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|February 17, 2006
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-CH Pelicano, J S Carew, T J McQueen, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Haematology and Blood Transfusion|January 1, 1979
Treatment of adult acute myeloblastic leukemiaK B McCredie, M J Keating, K A Dicke, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsV Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Leukemia & Lymphoma|July 27, 2016
Long-Term Results of CAP Therapy in Chronic Lymphocytic LeukemiaM J Keating, J P Hester, K B McCredie, et al.
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
International Journal of Oncology|February 17, 2000
Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic miceM A Haidar, T Manshouri, M J Keating, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 44